ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2018

Hexokinase 2 is targetable for HK1 negative, HK2 positive tumors from a wide variety of tissues of origin.

Shili Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.